Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter

被引:27
作者
Berry, NB
Cho, YM
Harrington, MA
Williams, SD
Foley, J
Nephew, KP
机构
[1] Indiana Univ, Sch Med, Bloomington, IN 47405 USA
[2] Indiana Univ, Ctr Canc, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Biochem, Indianapolis, IN 46202 USA
[4] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[5] Walther Canc Inst, Bloomington, IN 47405 USA
关键词
gene therapy; gynecologic oncology; tissue-specific promoter;
D O I
10.1016/j.ygyno.2003.12.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Limitations of current ovarian cancer gene therapies include lack of specificity and transduction of normal tissues. One strategy toward overcoming these limitations is to direct gene therapy specifically to ovarian cancer cells by using tissue- and tumor-specific promoters. The whey-acidic protein human epididymis protein 4 (HE4) is frequently overexpressed in ovarian cancer, suggesting that the HE4 promoter is highly transcriptionally active in the disease. The objective of this study was to isolate the HE4 promoter and examine its ability to selectively activate reporter gene expression in an ovarian cancer-specific manner. Methods. To investigate transcriptional targeting in ovarian cancer gene therapy, we isolated a region of the HE4 promoter from - 530 to + 122 (pHE4-652; relative to the ATG start site of HE4) and placed it upstream of a luciferase reporter gene plasmid to generate pHE4-652-luc. The activity of the pHE4-652-lue reporter construct was characterized in transient transfection assays in a panel of epithelial ovarian cancer cell lines (SKOV-3, SKOV-3 x, CP70, HeyC2, A2780, A2780CP, OVCAR-3), non-ovarian tumor cell lines, and primary cultures of normal cells. The activity of two other candidate gene therapy promoters, human telomerase reverse transcriptase (hTERT) and OSP1, was also characterized in these cell lines. Results. The HE4 promoter was active in 5/7 ovarian cancer cell lines with the range of activity spanning 0.06- to 3-fold that observed for a positive control, cotransfected reporter construct (SV-40-luc). Minimal pHE4-652 promoter activity, defined as :5 5% of the activity detected with the SV-40-luc construct, was observed in the non-ovarian tumor cell lines and normal cells. The hTERT and the OSPI promoters were active in the ovarian cancer lines. hTERT activity was highest in the CP70 cell line, and OSP1 activity was highest in the SKOV-3 x cell line. Modest OSPI and hTERT promoter activity was observed in normal cell lines and in selected non-ovarian cancer cell lines. Conclusion. This is the first report using the pHE4-652 promoter to drive specific reporter gene expression in epithelial ovarian cancer cell lines, and we are continuing to develop this promoter for use in transcriptional targeting in ovarian cancer gene therapy. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:896 / 904
页数:9
相关论文
共 48 条
[1]   DNA methylation and ovarian cancer [J].
Ahluwalia, A ;
Yan, P ;
Hurteau, JA ;
Bigsby, RM ;
Jung, SH ;
Huang, THM ;
Nephew, KP .
GYNECOLOGIC ONCOLOGY, 2001, 82 (02) :261-268
[2]  
Barnes MN, 2002, MOL CANCER THER, V1, P435
[3]  
Bauknecht Thomas, 2002, Curr Womens Health Rep, V2, P39
[4]   Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase [J].
Bilsland, AE ;
Anderson, CJ ;
Fletcher-Monaghan, AJ ;
McGregor, F ;
Evans, TRJ ;
Ganly, I ;
Knox, RJ ;
Plumb, JA ;
Keith, WN .
ONCOGENE, 2003, 22 (03) :370-380
[5]   The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms [J].
Bingle, L ;
Singleton, V ;
Bingle, CD .
ONCOGENE, 2002, 21 (17) :2768-2773
[6]   Cytokine-mediated induction of the human elafin gene in pulmonary epithelial cells is regulated by nuclear factor-κB [J].
Bingle, L ;
Tetley, TD ;
Bingle, CD .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 25 (01) :84-91
[7]   Advanced ovarian cancer. [J].
Chi D.S. ;
Sabbatini P. .
Current Treatment Options in Oncology, 2000, 1 (2) :139-146
[8]   A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein [J].
Clauss, A ;
Lilja, H ;
Lundwall, Å .
BIOCHEMICAL JOURNAL, 2002, 368 (01) :233-242
[9]   The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter [J].
Cong, YS ;
Wen, JP ;
Bacchetti, S .
HUMAN MOLECULAR GENETICS, 1999, 8 (01) :137-142
[10]   AN SRY-RELATED GENE EXPRESSED DURING SPERMATOGENESIS IN THE MOUSE ENCODES A SEQUENCE-SPECIFIC DNA-BINDING PROTEIN [J].
DENNY, P ;
SWIFT, S ;
CONNOR, F ;
ASHWORTH, A .
EMBO JOURNAL, 1992, 11 (10) :3705-3712